Moerae Matrix is a privately held biopharmaceutical company focused on the development of first-in-class targeted therapeutics for fibrotic disease. Based on proprietary technology from Purdue University, the company is advancing a suite of peptide therapeutics that target MAPKAP kinase 2 (MK2), a key terminal kinase in the TGF-beta/p38 pathway, with a high degree of specificity. Moerae Matrix’s first development candidate, MMI-0100, shows excellent activity in multiple models of fibrosis, including the bleomycin model of pulmonary fibrosis, in which MMI-0100 uniquely demonstrates potent anti-fibrotic activity even when administered days after the onset of injury. The compound has an excellent preclinical toxicology profile and is IND-ready for clinical development in acute fibrotic indications. Preclinical development is also underway with a pulmonary delivery formulation of MMI-0100 for chronic treatment of idiopathic pulmonary fibrosis (IPF).
 
Moerae Matrix has assembled an experienced management team which operates via a virtual, highly capital efficient model. The company completed a Series A financing in 2010 and has also successfully leveraged multiple sources of non-dilutive capital to support MMI-0100’s advancement. In addition to its seasoned board of directors, Moerae Matrix has aggregated a world-class network of pulmonary fibrosis advisors and collaborators to support the development of this potentially breakthrough therapeutic.
 
Our Purpose is creating innovative therapies that make sense

Our Vision is to better human health by safely and meaningfully alleviating the burden of disease and suffering

Our Core Values:

We will epitomize integrity – as individuals and as a company. Each of us is committed to being honest with ourself, our colleagues and the clinicians and patients who rely upon our company and our products. We pledge to honor their trust by exemplifying excellence, quality, reliability and respect for ourselves and others in everything that we do.

We will have courage – to step outside comfort zones, to stretch our capabilities, to challenge ourselves and our colleagues and to expend our fullest efforts so that we may achieve ever-greater products and real solutions. If we do risk and fail, we strive to fail fast, graciously take responsibility for our mistakes, and have the fortitude to persevere.

We will be practical and pragmatic in our work, without abandoning our idealistic pursuit or intellectual honesty. We pledge to rigorously evaluate our data, products and strategies without sentimentality or ego. We commit to work with efficiency and responsibility to key stakeholders uppermost in mind, expending effort and resources intelligently in pursuit of targeted goals.

We will maintain balance. As we pursue our vision of bettering human health, we will remember the needs of our own families, at home and at work, keeping their well-being uppermost in mind. We will nurture the personal growth and development of our associates and encourage each individual to take care of him- or herself.

We will enjoy the ride. Life is short and opportunities to be part of a dream team are rare. We will celebrate our colleagues and enjoy the journey that we are on together as a team. We will work hard to achieve great things – and enjoy ourselves in the process. While our work together is important and serious, we can accomplish even more if we have fun along the way.

Moerae will strive to be a great organization comprised of great individuals working together in great teams. We will park individual egos and strive to contribute to the needs of our teams and the company as a whole – always remembering what we are trying to accomplish together.